Embedded Files
Tres Alchemix Ltd.
Research and development of AI drag discovery platform
Establishment: April 24, 2023
Location: 2-19-17 Hakata-ekimae, Hakata-shi, Fukuoka
Team: Dr. Hisashi Hashimoto, CEO & o-founder
Dr. Takuma Morimoto, CSO & Co-founder
Dr. Ken Yamazaki, CTO & Co-founder
Ellen Zunker, COO
Dr. Masato Inoue, CPO
About Tres Alchemix
Founded in 2023 in the dynamic city of Fukuoka, Japan, we have established our research and development hub in Oxford, UK, to bring our technological innovations to the global market.
Tres Alchemix specialise in unraveling the complexity of the human body by harnessing the combined power of quantum-level chemical calculations and multi-omics AI. Our platforms provide highly accurate predictions of molecular behaviour, including chemical-protein interactions, pharmacokinetics and pharmacodynamics, offering unparalleled insights into the complex dynamics of drugs within the body. This cutting-edge technology forms the foundation of our way towards a holistic in silico human model, which will enable us to explore the root causes of various diseases and drive the development of novel therapeutics.
Members of Tres Alchemix Ltd.: Ellen Zunker, Dr. Takuma Morimoto, President Tanaka, Dr. Hisashi Hashimoto, and Dr. Masato Inoue at Pembroke College Oxrord
Tres Alchemix News
Tres Alchemix News
July 29, 2024
August 16, 2023
Page updated
Google Sites
Report abuse